For example, GBA mutations or MAPT H1 allele status might be independent risk factors for cognitive impairment in PD patients and the knowledge of these allele statuses in patients could have an impact on the treatment plan (Clarimón and Kulisevsky, 2013). This evidence concerns the gene MAPT and Parkinson disease.